HELM AG Acquires Shares in Amarin Technologies S.A.

Hamburg, Germany, December 15, 2010 / b3c newswire / - Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development company in Buenos Aires , Argentina .

Amarin has more than 20 years of experience in the technology of transdermal delivery systems and owns several patents. The mid-size company has been cooperating with HELM successfully on the development of a pain release patch.

Both Sergio Lucero, CEO of Amarin, and Dieter Schnabel, CEO of HELM, are convinced that HELM, with its marketing strength in more than 32 countries is a perfect fit for Amarin' s expertise in transdermal technology. " We are confident that this strategic step will be very beneficial to both companies."

The participation gives HELM' s pharmaceutical division direct access to various generic transdermal products, presently still a niche market but with strong growth potential. It will further strengthen the company' s position within the global pharmaceutical market. At the same time, it increases Amarin' s access to international markets.

For more information from HELM AG
Annegret Dehning
Executive Manager Admin./Public Relations
Tel. +49 40 23 75 18 20
e-mail: A.Dehning@helmag.com

For more information from Amarin Technologies SA
Ms. Emilce Diaz
Tel +54 11 5921 6387
e-mail: emilce.diaz@amarintech.com.ar